Rhoen Klinikum AG RHK

Morningstar Rating
€12.40 −0.20 (1.59%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RHK is trading at a 60% premium.
Price
€12.64
Fair Value
€98.65
Uncertainty
Very High
1-Star Price
€69.94
5-Star Price
€26.65
Economic Moat
Dfbxl
Capital Allocation

Trading Information

Previous Close Price
€12.60
Day Range
€12.4012.50
52-Week Range
€9.5014.00
Bid/Ask
€12.40 / €12.50
Market Cap
€830.04 Mil
Volume/Avg
2,160 / 1,964

Key Statistics

Price/Earnings (Normalized)
12.04
Price/Sales
0.56
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Small Core
Total Number of Employees
18,282

Comparables

Valuation

Metric
RHK
MD
AKT
Price/Earnings (Normalized)
12.0410.28
Price/Book Value
0.661.47
Price/Sales
0.560.50
Price/Cash Flow
8.668.04
Price/Earnings
RHK
MD
AKT

Financial Strength

Metric
RHK
MD
AKT
Quick Ratio
2.181.310.54
Current Ratio
2.341.380.60
Interest Coverage
14.02−5.4811.08
Quick Ratio
RHK
MD
AKT

Profitability

Metric
RHK
MD
AKT
Return on Assets (Normalized)
2.62%4.44%5.43%
Return on Equity (Normalized)
3.72%11.31%14.42%
Return on Invested Capital (Normalized)
2.90%8.59%10.12%
Return on Assets
RHK
MD
AKT

Medical Care Facilities Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA Healthcare Inc
HCA
CcxjpxcfVcdcytn$101.7 Bil
Fresenius SE & Co KGaA ADR
FSNUY
Fpvjqw$21.1 Bil
Fresenius SE & Co KGaA
FSNUF
Rzlcx$21.1 Bil
Tenet Healthcare Corp
THC
LfdyrjxDxbm$15.0 Bil
Universal Health Services Inc Class B
UHS
Rdqdddc$14.4 Bil
Bangkok Dusit Medical Services PCL ADR
BDUUY
Gbk$14.1 Bil
DaVita Inc
DVA
BkzmfdpsqJgnjwq$13.5 Bil
Fresenius Medical Care AG
FMCQF
Tzfkht$12.2 Bil
Fresenius Medical Care AG ADR
FMS
HhgvNldgt$12.2 Bil
Encompass Health Corp
EHC
Pwsyvrx$9.5 Bil

Sponsor Center